Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question.
Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question.
复制标题
DOI：
10.1016/j.schres.2010.03.012
复制
发表时间：
2010-07
影响因子：
4.5
通讯作者：
Corcoran, Cheryl M.
中科院分区：
文献类型：
--
作者：
Yang, Lawrence H.;Wonpat-Borja, Ahtoy J.;Opler, Mark G.;Corcoran, Cheryl M.
While the “high-risk state” for psychosis (or “prodrome”) has demonstrated good reliability and predictive validity for conversion to psychotic disorders, over 50% of identified subjects may not progress to psychosis. Despite the benefits that early detection and treatment might offer, debate concerning the official inclusion of a “psychosis risk syndrome” in the upcoming DSM-V frequently involves the threat of stigma’s impacts to patients, families, and institutions. We advance this debate by providing a focal analysis of the extensive theoretical and empirical stigma literature to better articulate stigma’s potential effects upon ‘prodromal’ individuals. Theorists’ conceptualizations of how stigma exerts its negative effects emphasize internalization of pejorative societal stereotypes (‘self-stigma’), negative emotional reactions, harmful behavioral coping strategies, and structural discrimination as key mechanisms. Studies assessing the comparative effects of symptomatic behavior when compared with a psychiatric label in predicting rejecting social attitudes indicate that treating symptomatic behaviors is likely to diminish overall stigma. However, any publically-held ‘preexisting conceptions’ about what a psychosis risk syndrome means are still likely to exert negative effects. Additionally, particular features of this syndrome—that it occurs during adolescence when identity formation is in flux--further shape manifestations of stigma. Utilizing other well-established ‘at-risk’ conditions (e.g., genetic susceptibility) to model potential discrimination for this syndrome, we suggest that future discrimination may likely occur in insurance and family domains. We conclude by proposing stigma measurement strategies, including recommending that field trials prior to DSM-V adopt systematic measures to assess any stigma that this psychosis risk syndrome might confer via future community use.
登录
查看更多内容
DOI：
10.1080/00332747.1981.11024117
发表时间：
1981-01-01
影响因子：
2.4
作者：
CLAUSEN, JA
通讯作者：
CLAUSEN, JA
影响因子：
1.7
作者：
Corrigan, Patrick W.;Watson, Amy C.;Barr, Leah
通讯作者：
Barr, Leah
影响因子：
6.6
作者：
LALLY, SJ
通讯作者：
LALLY, SJ
影响因子：
4.5
作者：
Corcoran, C;Malaspina, D;Hercher, L
通讯作者：
Hercher, L
影响因子：
3.8
作者：
Corrigan, PW;Lurie, BD;Phelan, S
通讯作者：
Phelan, S